Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma

Zhang, YC; Wang, JN; Ma, SY; Cai, J; Su, N; Huang, HQ; Li, ZM; Xia, ZJ; Huang, H; Liu, PP; Xia, Y; Cai, QQ

Cai, QQ (通讯作者)，Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Peoples R China.

BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (1): 127

Abstract

Patients with classical Hodgkin lymphoma (cHL) who do not achieve complete remission (CR) after second-line chemotherapy have poor clinical outcomes. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索